New criteria for diagnosing, staging Alzheimer’s stirs controversy
By
Kristen Fischer
Jul 01, 2024
The Alzheimer’s Association set out new criteria for diagnosing and staging Alzheimer’s based on recent advancements, especially biomarkers that can biologically detect the disease instead of relying...
Older adults who volunteered more often had better emotional well-being, were less likely to have Alzheimer’s disease and had lower risks for not being able to perform activities of daily living.
Clinical briefs for Tuesday, August 1
By
Kristen Fischer
Aug 01, 2023
Vaccine for Alzheimer’s disease gets its start … Free online Parkinson’s course offers information for paid caregivers … Neurologists share tips for Alzheimer’s drugs … Eye experts offer safety...
Clinical briefs for Monday, March 11
By
Kristen Fischer
Mar 11, 2024
FDA holds off on approval for Alzheimer’s drug donanemab … Ageism has overshadowed mental health, experts say … Drug trio best for pain control after hip surgery … Probiotics linked to better cognitive...
Study: Having two copies of gene mutation linked to Alzheimer’s may cause onset
By
Kristen Fischer
May 07, 2024
A new study finds that possessing two copies of a specific gene mutation that’s common in Alzheimer’s disease may be the cause behind the disease in those people.
Clinical briefs for Tuesday, Sept. 19
By
Kristen Fischer
Sep 19, 2023
Here’s how many nursing homes can meet proposed staffing requirements … Slim reimbursement for lumbar puncture an obstacle for Alzheimer’s care … Health, food policies could aid antimicrobial resistance...
Vigorous exercise may guard against death from Alzheimer’s disease
By
Kristen Fischer
Dec 18, 2023
Engaging in vigorous activity compared to moderate exercise may lower the rate of dying from Alzheimer’s disease, according to a new study. The study was published in the December issue of The Lancet...
Mid-life racial discrimination in Black Americans tied to Alzheimer’s later on, study finds
By
Kristen Fischer
Apr 12, 2024
Racial discrimination during midlife is linked to Alzheimer’s disease, a new study finds.
FDA fast-tracked dementia drug with known harms, reporter says
By
Kristen Fischer
Aug 18, 2023
An article in The BMJ is sounding the alarm that the US Food and Drug Administration fast-tracked approval for the dementia drug Rexulti (brexpiprazole) — even though trials show the drug is harmful.
Report: Monoclonal antibodies for dementia lack clear benefits, show risks
By
Kristen Fischer
Jan 23, 2024
Even though amyloid-reducing monoclonal antibodies (MABs) are on the market and some research shows they may treat Alzheimer’s disease and dementia, a new research review found there aren’t clear benefits...